[go: up one dir, main page]

NO20002149D0 - Procedure for reducing mammalian addiction - Google Patents

Procedure for reducing mammalian addiction

Info

Publication number
NO20002149D0
NO20002149D0 NO20002149A NO20002149A NO20002149D0 NO 20002149 D0 NO20002149 D0 NO 20002149D0 NO 20002149 A NO20002149 A NO 20002149A NO 20002149 A NO20002149 A NO 20002149A NO 20002149 D0 NO20002149 D0 NO 20002149D0
Authority
NO
Norway
Prior art keywords
addiction
procedure
reducing mammalian
mammalian
reducing
Prior art date
Application number
NO20002149A
Other languages
Norwegian (no)
Other versions
NO20002149L (en
Inventor
Vicki Coffin
Paul Glue
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20002149D0 publication Critical patent/NO20002149D0/en
Publication of NO20002149L publication Critical patent/NO20002149L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20002149A 1997-10-28 2000-04-27 Procedure for reducing mammalian addiction NO20002149L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95921397A 1997-10-28 1997-10-28
PCT/US1998/022255 WO1999021540A2 (en) 1997-10-28 1998-10-26 Method of reducing craving in mammals

Publications (2)

Publication Number Publication Date
NO20002149D0 true NO20002149D0 (en) 2000-04-27
NO20002149L NO20002149L (en) 2000-06-26

Family

ID=25501785

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002149A NO20002149L (en) 1997-10-28 2000-04-27 Procedure for reducing mammalian addiction

Country Status (16)

Country Link
EP (1) EP1043980A2 (en)
JP (1) JP2001520989A (en)
KR (1) KR20010031470A (en)
CN (1) CN1283116A (en)
AR (1) AR015984A1 (en)
AU (1) AU1110099A (en)
BR (1) BR9814830A (en)
CA (1) CA2308453A1 (en)
CO (1) CO4970824A1 (en)
HU (1) HUP0100115A2 (en)
IL (1) IL135659A0 (en)
NO (1) NO20002149L (en)
PE (1) PE122299A1 (en)
SK (1) SK5812000A3 (en)
WO (1) WO1999021540A2 (en)
ZA (1) ZA989786B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410527B1 (en) * 1998-03-02 2002-06-25 Schering Corporation Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism
ZA991638B (en) * 1998-03-02 1999-09-01 Schering Corp Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders and autism.
US6890951B2 (en) 1998-08-05 2005-05-10 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior
US6541520B1 (en) 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
IL137937A0 (en) * 1999-08-27 2001-10-31 Pfizer Prod Inc A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
US6395783B1 (en) 2000-10-23 2002-05-28 Brookhaven Science Associates, Llc Treatment of PCP addiction and PCP addiction-related behavior
US6462084B1 (en) 2001-05-14 2002-10-08 Brookhaven Science Associates, Llc Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG
NZ532583A (en) 2001-11-05 2006-12-22 Krele Pharmaceuticals Compositions and methods for increasing compliance using aldehyde dehydrogenase inhibitors ( ALDH ) such as disulfiram and monoamine oxidase B inhibitors ( MAOB ) such as selegiline
JP6355921B2 (en) 2010-09-01 2018-07-11 トニックス ファーマスーティカルズ, インコーポレイテッドTONIX Pharmaceuticals, Inc. Treatment of addiction to cocaine
AU2013289922B2 (en) 2012-07-12 2016-12-15 Psyadon Pharmaceuticals, Inc. Fused benzazepines for treatment of Tourette's Syndrome
US9949983B2 (en) 2013-10-18 2018-04-24 Psyadon Pharmaceuticals, Inc. Fused benzazepines for treatment of stuttering
CN110327350B (en) * 2019-07-11 2021-02-23 温州医科大学 Application of dopamine D1 receptor antagonist SCH39166 as a drug for the treatment of ocular pathological angiogenesis
CN110833621A (en) * 2019-12-06 2020-02-25 中国医科大学 Application of dopamine receptor 1 antagonists in the preparation of drugs for the treatment of schizophrenia-like mice induced by ketamine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607967A (en) * 1994-10-27 1997-03-04 Merck & Co., Inc. Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan carboxylic acid
AU3408097A (en) * 1996-06-06 1998-01-05 Ergo Research Corporation Treatment of lipid and glucose metabolism disorders with dopamine and seroto nin agonists

Also Published As

Publication number Publication date
JP2001520989A (en) 2001-11-06
AR015984A1 (en) 2001-05-30
PE122299A1 (en) 1999-12-04
BR9814830A (en) 2000-10-03
IL135659A0 (en) 2001-05-20
NO20002149L (en) 2000-06-26
WO1999021540A3 (en) 1999-09-02
KR20010031470A (en) 2001-04-16
AU1110099A (en) 1999-05-17
WO1999021540A2 (en) 1999-05-06
ZA989786B (en) 1999-04-28
EP1043980A2 (en) 2000-10-18
WO1999021540B1 (en) 1999-10-28
HUP0100115A2 (en) 2001-06-28
CN1283116A (en) 2001-02-07
CA2308453A1 (en) 1999-05-06
SK5812000A3 (en) 2000-12-11
CO4970824A1 (en) 2000-11-07

Similar Documents

Publication Publication Date Title
FI972024L (en) Handover method
FI962231A0 (en) Traeskelarrangemang hos en hisskorg
DK0964665T3 (en) Absorbent for absorbent garments
NO20002135D0 (en) reflectometer
DE69806599D1 (en) MULTIPLE-FLASHPOINT EXPANSION SYSTEM
DE69840547D1 (en) INTERFACE SYSTEM FOR GLASSES
FI970036L (en) Method for managing repeaters
ID23013A (en) PHARMACOLOGICAL INGREDIENTS
NO20002149D0 (en) Procedure for reducing mammalian addiction
DE69830200D1 (en) EXPANSION PROCESS
DE69832848D1 (en) PLC synchronization method
DE69827000D1 (en) NEW PROCEDURE
DE69840366D1 (en) SYSTEM FOR TAKING PROGRAM
FI972108A7 (en) Method for transferring parameters
NO996254D0 (en) Synchronization procedure
ID17067A (en) SIMPLE DISPLAY METHOD FOR CONNECTION AREA
FI970793L (en) Method for disconnecting connections
DE59809195D1 (en) blowpipe
FI971257A7 (en) Cold forming method
DE59701604D1 (en) SYNCHRONIZATION PROCEDURE
FI973099A0 (en) Installationsanordning hos balkongglasering
EE9900404A (en) Method for the preparation of arylaminotriazolopyridines
FI971230L (en) Synchronization method
NO964439L (en) For
FI970485A0 (en) Styrsystem hos en inmatningsanordning av en harvestermaskin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application